IFNA2 抗体 (Biotin)
(5 references)Quick Overview for IFNA2 抗体 (Biotin) (ABIN6963844)
抗原
See all IFNA2 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
特异性
- Native and recombinant human IFN-α subtypes 2a, 2b, 2c
-
纯化方法
- Biotinylated through reaction with a N-hydroxysuccinimide ester of biotin.,Purified from in vitro cultures by protein G affinity chromatography.
-
过滤
- 0.2 μm filtered
-
免疫原
- Recombinant human IFN-alpha 2c
-
亚型
- IgG1
-
-
anti-Interferon, alpha 2 (IFNA2) (AA 24-188) antibody
IFNA2 适用: 人 ELISA, WB, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Interferon, alpha 2 (IFNA2) (AA 24-188) antibodyIFNA2 适用: 人 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Interferon, alpha 2 (IFNA2) (C-Term) antibodyIFNA2 适用: 人 WB, IF, ICC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Interferon, alpha 2 (IFNA2) (AA 1-188) antibodyIFNA2 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Interferon, alpha 2 (IFNA2) (AA 24-188) antibodyIFNA2 适用: 人 ELISA, WB 宿主: 小鼠 Monoclonal 2B1 unconjugated
anti-Interferon, alpha 2 (IFNA2) (AA 24-188) antibodyIFNA2 适用: 人 ELISA, WB 宿主: 小鼠 Monoclonal 1F8 unconjugated
anti-Interferon, alpha 2 (IFNA2) (N-Term) antibodyIFNA2 适用: 人 ELISA, WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Interferon, alpha 2 (IFNA2) (AA 24-192) antibodyIFNA2 适用: 大鼠 WB, IHC, IP, ICC 宿主: 兔 Polyclonal unconjugated
anti-Interferon, alpha 2 (IFNA2) antibodyIFNA2 适用: 人 ELISA, WB 宿主: 兔 Polyclonal unconjugated
anti-Interferon, alpha 2 (IFNA2) (AA 24-188) antibodyIFNA2 适用: 人 WB 宿主: 小鼠 Monoclonal D4 unconjugated
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 mg/mL
-
缓冲液
- supplied at 1 mg/mL in PBS with 0.02 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store product at 4-8°C or frozen at -20°C or below. Avoid repeated freezing/ thawing.
-
有效期
- 18 months
-
-
-
: "Distribution of therapeutic proteins into thoracic lymph after intravenous administration is protein size-dependent and primarily occurs within the liver and mesentery." in: Journal of controlled release : official journal of the Controlled Release Society, Vol. 272, pp. 17-28, (2019) (PubMed).
: "Evaluation of modified Interferon alpha mRNA constructs for the treatment of non-melanoma skin cancer." in: Scientific reports, Vol. 8, Issue 1, pp. 12954, (2019) (PubMed).
: "An Evaluation of Optimal PEGylation Strategies for Maximizing the Lymphatic Exposure and Antiviral Activity of Interferon after Subcutaneous Administration." in: Biomacromolecules, Vol. 18, Issue 9, pp. 2866-2875, (2018) (PubMed).
: "Flavonolignans Inhibit IL1-β-Induced Cross-Talk between Blood Platelets and Leukocytes." in: Nutrients, Vol. 9, Issue 9, (2018) (PubMed).
: "Lymphocytes eject interferogenic mitochondrial DNA webs in response to CpG and non-CpG oligodeoxynucleotides of class C." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, Issue 3, pp. E478-E487, (2018) (PubMed).
-
: "Distribution of therapeutic proteins into thoracic lymph after intravenous administration is protein size-dependent and primarily occurs within the liver and mesentery." in: Journal of controlled release : official journal of the Controlled Release Society, Vol. 272, pp. 17-28, (2019) (PubMed).
-
- IFNA2 (Interferon, alpha 2 (IFNA2))
-
别名
- IFNA2
-
基因ID
- 3440
-
途径
- JAK/STAT Signaling, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Hepatitis C
抗原
-
